New Trustees appointed to the Franklin’s Board
The Rosalind Franklin Institute has appointed four new trustees: Malcolm Skingle, Hilary Newiss, Bruce Pritchard and Caroline Carter. Our new trustees come from a diverse range of backgrounds, with a wealth of expertise and skills which will be a great…
New technique sheds light on how proteins organise and move on cell membranes
Researchers at the Rosalind Franklin Institute, the University of Oxford and the University of Southern California have developed a new method for studying how molecules behave on the cell membrane. The technique, known as brightness-transit statistics (BTS), will enhance our…
The Franklin’s 2024 Summer Interns
For the fourth year the Rosalind Franklin Institute has hosted summer interns as part of the Health Data Research internship programme. This year Semhar Misghina and Melissa Mitchell joined the Artificial Intelligence and Informatics team throughout July and August hosted by…
Imaging in liquid with unprecedented clarity
Researchers at the Rosalind Franklin Institute have made a significant breakthrough by imaging bacteria in liquid with unprecedented clarity. Published in the journal Small, this advancement in Liquid Phase Electron Microscopy (LPEM) allows scientists to study biological molecules in their natural…
New collaboration with Mary Lyons Centre to develop novel radiotracers
The Rosalind Franklin Institute and Mary Lyon Centre are collaborating on a new project which will explore new ways of chemically labelling living cells. These new labels will open up new ways of probing and understanding biology. Positron Emission Tomography,…
Exploration of unwanted immune response to penicillin lays groundwork for better drug design
Around 6% of people in the UK are allergic to penicillin according to their medical records – the most commonly reported drug allergy. And although research suggests the majority of those patients could, in practice, tolerate the drug, penicillin allergy…
Collaborating to apply new imaging techniques to explore causes of neurodegenerative conditions
The Rosalind Franklin Institute (the Franklin) have embarked on a new collaboration with global biopharmaceutical leader, MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA). Together, researchers will look at cell regulation and how malfunctioning of specific cell regulation…
Biotech deal paves way for new COVID-19 treatments and more
The Franklin’s first licensing agreement – with US-based IntegerBio – advances its pioneering nanobody technology with industry. The days of lockdowns, televised news conferences and one-way systems in supermarkets may, for many of us, be a distant memory. But pandemics…
Celebrating a petabyte of data collected at the Franklin
The Rosalind Franklin Institute has recently celebrated a massive data milestone, collecting one Petabyte of data from its research efforts. One petabyte of data is the equivalent of 500 billion pages of standard typed text. For the Franklin, this data…
Llama derived nanobodies neutralising new strains of coronavirus.
Specific nanobodies have been isolated that can neutralise Omicron strains of Covid-19. This research, conducted by scientists at the Rosalind Franklin Institute and the Universities of Oxford, Liverpool and Zurich, has been published in Open Biology. The landscape of SARS-CoV-2 variants…